| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Brimonidine tartrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brimonidine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely brimonidine tartrate 2 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brimonidine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Brimonidine tartrate 0.2% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brimonidine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Brimonidine tartrate 1.5 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brimonidine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Brimonidine tartrate 1 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brimonidine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Brimonidine 0.2%/timolol 0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brimonidine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely brimonidine tartrate 2 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has precise active ingredient |
True |
Brimonidine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely brimonidine tartrate 2 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Brimonidine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Brimonidine tartrate 1.5 mg/mL eye solution |
Has precise active ingredient |
True |
Brimonidine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Brimonidine tartrate 1.5 mg/mL eye solution |
Has basis of strength substance (attribute) |
True |
Brimonidine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Brimonidine tartrate 1 mg/mL eye solution |
Has precise active ingredient |
True |
Brimonidine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Brimonidine tartrate 1 mg/mL eye solution |
Has basis of strength substance (attribute) |
True |
Brimonidine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and timolol 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Brimonidine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and timolol 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has precise active ingredient |
True |
Brimonidine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Brimonidine (as brimonidine tartrate) 3.3 mg/g cutaneous gel |
Has precise active ingredient |
True |
Brimonidine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and brinzolamide 10 milligram/1 milliliter conventional release suspension for eye drops (clinical drug) |
Has precise active ingredient |
True |
Brimonidine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and brinzolamide 10 milligram/1 milliliter conventional release suspension for eye drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Brimonidine tartrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]